ACE — Ascelia Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK71.37m
- SEK33.84m
Brief: Ascelia Pharma Q3 EBIT SEK -10.4 Million
Sweden's Ascelia Pharma Q2 operating loss narrows
Brief: Ascelia Pharma Q2 EBIT SEK -12.1 Million
Brief: FDA Accepts Ascelia Pharma Type A Meeting Request
Brief: Ascelia Pharma CFO Anton Hansson To Leave Co
Brief: Ascelia Pharma Receives FDA Complete Response Letter For Orviglance NDA
Brief: Ascelia Pharma Files Patent Application For Orviglance Liver Imaging Drug
Sweden's Ascelia Pharma Q1 loss narrows
Brief: Ascelia Pharma Q1 EBIT SEK -17.2 Million
Brief: Ascelia Pharma Q4 EPS Loss Narrows To Sek 0.13
Sweden's Ascelia Pharma Q4 operating loss narrows to SEK 15.8 mln
Brief: Ascelia Pharma CFO, Deputy CEO Julie Waras Brogren To Leave
Brief: FDA Sets Review Date For Ascelia Pharma's Orviglance NDA For July 3
Brief: Ascelia Pharma Files New Patent Application For Orviglance
Brief: Ascelia Pharma Q3 EBIT SEK -15.3 Million
Brief: Ascelia Pharma Recruits Anton Hansson As CFO
Brief: Ascelia Pharma Completes Directed Share Issue
Brief: Ascelia Pharma Submits Orviglance New Drug Application To FDA
Brief: Ascelia Pharma Q2 Operating Loss At SEK 23 Mln